Latest Asx News

Wia Gold Limited has delivered a robust Scoping Study for its Kokoseb Gold Project in Namibia, confirming strong production potential and cost efficiency. The company also secured A$30 million to accelerate exploration and development activities.

Liontown Resources delivered a robust September quarter with a significant ramp-up in underground mining at Kathleen Valley, alongside a fortified cash position and strategic contract amendments.

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy, advancing licensing negotiations for its first CAR-T product and raising $1.6 million through placements to bolster its financial position.

NH3 Clean Energy has secured key government approval that streamlines regulatory processes for its WAH2 low-emissions ammonia project, keeping it on track for first production by 2026. This milestone underscores growing state support for decarbonisation initiatives in Western Australia’s strategic industrial zones.

Global Health Limited has accelerated its MasterCare+ SaaS platform rollout, integrating AI to streamline operations and reduce staff by 10%, while reporting a 25% EBIT improvement despite a delayed R&D refund impacting cash flow.

Alvo Minerals has confirmed significant zinc and copper anomalies at its newly discovered Touro Prospect within the Palma VMS Project in Brazil, positioning it as the next major drill target. Extensive geochemical and geophysical surveys underpin this promising development.

Resouro Strategic Metals has engaged Independent Trading Group to provide market-making services on the TSX Venture Exchange, aiming to enhance liquidity and trading efficiency for its shares. This move comes as the company continues to advance its significant Brazilian mineral projects.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Tarrina Resources is set to acquire promising exploration assets in NSW and SA, backed by a $5 million capital raise. The move aims to reposition the company within the mining sector and secure its ASX listing.

CONNEQT Health has landed a significant Phase 2b clinical trial contract in the US, advancing its footprint in cardiovascular disease research with proprietary vascular assessment technology.

Starpharma has secured two major partnership agreements with Genentech and Radiopharm Theranostics, unlocking significant upfront payments and milestone potential while advancing its clinical pipeline.